Cerulean Offers CRLX101 Combo Data at ASCO
June 03, 2014 at 09:08 AM EDT
Cerulean Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting™, announced today that three abstracts on its lead candidate, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.